JNJ
JOHNSON & JOHNSON
JOHNSON & JOHNSON (JNJ) has 11 SEC Form 4 filings (101 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: May 4, 2026.
Insiders have net sold $57.0M over the trailing 6 months.
- Industry:Drug Manufacturers - General
- CEO:Joaquin Duato
- Employees:141,700
- HQ:New Brunswick, NJ, US
- IPO:1962-01-02
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$57.0M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$601.7B
latest known value
Earnings: last 7 quarters
EstimatedActual
| Source | ||||||
|---|---|---|---|---|---|---|
Wolk Joseph JFirst filing | Exec VP, CFO | Sale | 89,654 | $21.8M | Feb 18 | SEC ↗ |
Swanson James D.First filing | EVP, CIO | Sale | 41,559 | $10.1M | Feb 18 | SEC ↗ |
Swanson James D.First filing | EVP, CIO | Sale | 20,521 | $5.0M | Feb 18 | SEC ↗ |
REED JOHN CFirst filing | EVP, Innovative Medicine, R&D | Sale | 53,931 | $13.1M | Feb 18 | SEC ↗ |
Schmid TimothyFirst filing | EVP, WW Chair, MedTech | Sale | 22,623 | $5.5M | Feb 18 | SEC ↗ |
Broadhurst VanessaFirst filing | EVP, Global Corp Affairs | Sale | 6,197 | $1.5M | Feb 18 | SEC ↗ |
Congress trading JNJ
See timeline →- RRep. Thomas H. KeanSale$1,001 - $15,0002026-06-02
- RRep. Thomas H. KeanSale$1,001 - $15,0002026-06-29
- DRep. Lloyd DoggettPurchase$1,001 - $15,0002026-06-09
- DRep. Ro KhannaSale$1,001 - $15,0002026-05-01
- DRep. Ro KhannaPurchase$15,001 - $50,0002026-04-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
JOHNSON & JOHNSON is in the Healthcare sector.